Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 129 results
Advanced filters: Author: Emma Dean Clear advanced filters
  • An analysis of 24,202 critical cases of COVID-19 identifies potentially druggable targets in inflammatory signalling (JAK1), monocyte–macrophage activation and endothelial permeability (PDE4A), immunometabolism (SLC2A5 and AK5), and host factors required for viral entry and replication (TMPRSS2 and RAB2A).

    • Erola Pairo-Castineira
    • Konrad Rawlik
    • J. Kenneth Baillie
    ResearchOpen Access
    Nature
    Volume: 617, P: 764-768
  • High-depth sequencing of non-cancerous tissue from patients with metastatic cancer reveals single-base mutational signatures of alcohol, smoking and cancer treatments, and reveals how exogenous factors, including cancer therapies, affect somatic cell evolution.

    • Oriol Pich
    • Sophia Ward
    • Nicholas McGranahan
    ResearchOpen Access
    Nature
    P: 1-11
  • Governments, universities and journals all have roles to play in dealing with fraud, says Emma Marris.

    • Emma Marris
    News
    Nature Medicine
    Volume: 12, P: 491
  • Hutchinson-Gilford Progeria Syndrome is characterized by premature aging with cardiovascular disease being the main cause of death. Here the authors show that inhibition of the NAT10 enzyme enhances cardiac function and fitness, and reduces age-related phenotypes in a mouse model of premature aging.

    • Gabriel Balmus
    • Delphine Larrieu
    • Stephen P. Jackson
    ResearchOpen Access
    Nature Communications
    Volume: 9, P: 1-14
  • Many premalignant colorectal polyps in familial adenomatous polyposis arise polyclonally rather than from a single mutated cell, showing diverse early evolutionary trajectories that frequently occur without clonal APC or KRAS driver events.

    • Debra Van Egeren
    • Ryan O. Schenck
    • Christina Curtis
    ResearchOpen Access
    Nature
    P: 1-8
  • St Louis wants to become a hub of agricultural biotechnology. All it needs, says Emma Marris, is more start-ups and funds.

    • Emma Marris
    Comments & Opinion
    Nature
    Volume: 452, P: 122-124
  • There are worse places to do research, but for the Caribbean cruise ship Explorer of the Seas, home to two climate laboratories, it's not all smooth sailing. Emma Marris finds out why.

    • Emma Marris
    News
    Nature
    Volume: 431, P: 394-395
  • Developmental disorders (DDs) are more prevalent in males, thought to be due to X-linked genetic variation. Here, the authors investigate the burden of X-linked coding variants in 11,044 DD patients, showing that this contributes to ~6% of both male and female cases and therefore does not solely explain male bias in DDs.

    • Hilary C. Martin
    • Eugene J. Gardner
    • Matthew E. Hurles
    ResearchOpen Access
    Nature Communications
    Volume: 12, P: 1-13
  • ‘T cell engagers promote antitumor immunity, but how macrophage modulates this activity in tumor is still unclear. Here the authors show, using biopsies from patients with uveal melanoma and single cell analyses, that a T cell engager, tebentafusp, reprograms tumor-associated macrophages and ameliorates, in synergy with IL-2, immunosuppression to cancer.

    • Esra Güç
    • Agatha Treveil
    • Adel Benlahrech
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-16
  • A study of SARS-CoV-2 variants examining their transmission, infectivity, and potential resistance to therapies provides insights into the biology of the Delta variant and its role in the global pandemic.

    • Petra Mlcochova
    • Steven A. Kemp
    • Ravindra K. Gupta
    ResearchOpen Access
    Nature
    Volume: 599, P: 114-119
  • In this study, Aggarwal and colleagues perform prospective sequencing of SARS-CoV-2 isolates derived from asymptomatic student screening and symptomatic testing of students and staff at the University of Cambridge. They identify important factors that contributed to within university transmission and onward spread into the wider community.

    • Dinesh Aggarwal
    • Ben Warne
    • Ian G. Goodfellow
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-16
  • Whole-genome sequencing analysis of individuals with primary immunodeficiency identifies new candidate disease-associated genes and shows how the interplay between genetic variants can explain the variable penetrance and complexity of the disease.

    • James E. D. Thaventhiran
    • Hana Lango Allen
    • Kenneth G. C. Smith
    Research
    Nature
    Volume: 583, P: 90-95
  • Chromodomain Helicase DNA-binding (CHD) proteins have been implicated in neurodevelopmental processes. Here, the authors identify missense variants in CHD3 that disturb its chromatin remodeling activities and cause a neurodevelopmental disorder with macrocephaly and speech and language impairment.

    • Lot Snijders Blok
    • Justine Rousseau
    • Philippe M. Campeau
    ResearchOpen Access
    Nature Communications
    Volume: 9, P: 1-12
  • Assessing the value of genomics is key to informing evidence-based policies; this Review outlines how current approaches to health technology assessment, implementation and data management can be adapted to suit the rapidly evolving technology and evidence base.

    • Ilias Goranitis
    • Robin Z. Hayeems
    • Zornitza Stark
    Reviews
    Nature Medicine
    Volume: 31, P: 4022-4033
  • The heterogeneity of androgen receptor (AR) gene alterations across metastases in prostate cancer remains unresolved. Here, the authors characterise AR genomic complexity across spatially separated lethal metastases from 10 prostate cancer patients and investigate how AR alterations evolve.

    • A. M. Mahedi Hasan
    • Paolo Cremaschi
    • Gerhardt Attard
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-16
  • A longitudinal evolutionary analysis of 126 lung cancer patients with metastatic disease reveals the timing of metastatic divergence, modes of dissemination and the genomic events subject to selection during the metastatic transition.

    • Maise Al Bakir
    • Ariana Huebner
    • Charles Swanton
    ResearchOpen Access
    Nature
    Volume: 616, P: 534-542
  • Analyses of multiregional tumour samples from 421 patients with non-small cell lung cancer prospectively enrolled to the TRACERx study reveal determinants of tumour evolution and relationships between intratumour heterogeneity and clinical outcome.

    • Alexander M. Frankell
    • Michelle Dietzen
    • Charles Swanton
    ResearchOpen Access
    Nature
    Volume: 616, P: 525-533
  • Whole-exome analysis of individuals with developmental disorders shows that de novo mutations can equally cause loss or altered protein function, but that most mutations causing altered protein function have not yet been described.

    • Jeremy F. McRae
    • Stephen Clayton
    • Matthew E. Hurles
    Research
    Nature
    Volume: 542, P: 433-438
  • Immune lymphocyte estimation from nucleotide sequencing (ImmuneLENS) infers B cell and T cell fractions from whole-genome sequencing data. Applied to the 100,000 Genomes Project datasets, circulating T cell fraction provides sex-dependent and prognostic insights in patients.

    • Robert Bentham
    • Thomas P. Jones
    • Nicholas McGranahan
    ResearchOpen Access
    Nature Genetics
    Volume: 57, P: 694-705
    • Emma Greenwood
    Research Highlights
    Nature Reviews Cancer
    Volume: 3, P: 714
    • Emma Greenwood
    Research Highlights
    Nature Reviews Cancer
    Volume: 2, P: 560
  • The ATR inhibitor ceralasertib has shown clinical activity in combination with immune-checkpoint inhibitors in several cancer types. Here the authors report the anti-tumor activity and the immunomodulatory changes, dependent on up-regulation of type I interferon pathway, following intermittent ATR inhibition in preclinical cancer models.

    • Elizabeth L. Hardaker
    • Emilio Sanseviero
    • Simon T. Barry
    ResearchOpen Access
    Nature Communications
    Volume: 15, P: 1-20
  • St. Louis wants to become a hub of agricultural biotechnology. All it needs is more start-ups and funds.

    • Emma Marris
    Comments & Opinion
    Nature Biotechnology
    Volume: 26, P: 471-472
  • Analyses of the TRACERx study unveil the relationship between tissue morphology, the underlying evolutionary genomic landscape, and clinical and anatomical relapse risk of lung adenocarcinomas.

    • Takahiro Karasaki
    • David A. Moore
    • Mariam Jamal-Hanjani
    Research
    Nature Medicine
    Volume: 29, P: 833-845
  • Major histocompatibility complex (MHC) loss of heterozygosity, allele-specific mutation and measurement of expression and repression (MHC Hammer) detects disruption to human leukocyte antigens due to mutations, loss of heterogeneity, altered gene expression or alternative splicing. Applied to lung and breast cancer datasets, the tool shows that these aberrations are common across cancer and can have clinical implications.

    • Clare Puttick
    • Thomas P. Jones
    • Nicholas McGranahan
    ResearchOpen Access
    Nature Genetics
    Volume: 56, P: 2121-2131
  • Fungal spores can promote immune responses of both type 2 (IL-4 / IL-5 / IL-13) and type 17 (IL-17). Here the authors characterise the subsets of cDC2 associated with type 2 and type 17 allergic responses to fungal allergens and show that Mgl2+ cDC2 depletion reduces type 2 but not type 17 fungal airway inflammation.

    • Peter C. Cook
    • Sheila L. Brown
    • Andrew S. MacDonald
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-18
  • In the phase 2 HUDSON study, patients with advanced non-small-cell lung cancer received anti-PD-L1 combined with biomarker-guided therapy targeting ATR kinase, PARP, STAT3 or CD73, leading to encouraging clinical benefit in response to combination of the ATR kinase inhibitor ceralasertib with durvalumab.

    • Benjamin Besse
    • Elvire Pons-Tostivint
    • John V. Heymach
    ResearchOpen Access
    Nature Medicine
    Volume: 30, P: 716-729
  • Circulating tumour DNA profiling in early-stage non-small-cell lung cancer can be used to track single-nucleotide variants in plasma to predict lung cancer relapse and identify tumour subclones involved in the metastatic process.

    • Christopher Abbosh
    • Nicolai J. Birkbak
    • Charles Swanton
    Research
    Nature
    Volume: 545, P: 446-451
  • Computational and machine-learning approaches that integrate genomic and transcriptomic variation from paired primary and metastatic non-small cell lung cancer samples from the TRACERx cohort reveal the role of transcriptional events in tumour evolution.

    • Carlos Martínez-Ruiz
    • James R. M. Black
    • Nicholas McGranahan
    ResearchOpen Access
    Nature
    Volume: 616, P: 543-552
  • Overexpression of human antigen R (HuR) correlates with high grade tumours and poor patient prognosis. Here, the authors engineer a TRIM21 biological PROTAC to demonstrate the benefit of a targeted protein degradation approach to deplete HuR, resulting in tumour growth inhibition in pre-clinical cancer models by altering the HuR-regulated proteome.

    • Alice Fletcher
    • Dean Clift
    • James Hunt
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-14
  • DNA-dependent protein kinase (DNA-PK) plays a major role in the DNA damage response upon double-strand break formation. Here, the authors show that the DNA-PK inhibitor AZD7648, enhances the activity of radiotherapy, chemotherapy and the PARP inhibitor olaparib in multiple mouse tumour models.

    • Jacqueline H. L. Fok
    • Antonio Ramos-Montoya
    • Elaine B. Cadogan
    ResearchOpen Access
    Nature Communications
    Volume: 10, P: 1-15
  • It is shown that mice deficient for β8 integrin develop colitis, and that β8 needs to be expressed by dendritic cells rather than T cells for colitis to develop. In addition, a decrease of T cells in the gut but not adjacent lymph nodes in diseased animals is shown. It is concluded that αVβ8-mediated integrin activation of dendritic cells is essential for prevention of colitis-inducing immune dysfunction.

    • Mark A. Travis
    • Boris Reizis
    • Dean Sheppard
    Research
    Nature
    Volume: 449, P: 361-365
  • Inflammatory skin diseases are frequently associated with dysregulation of cutaneous immunity. Here the authors perform human challenge with house dust mite allergen in patients with atopic dermatitis and explore the molecular network determining tolerance versus inflammation and identify a role for metallothioneins in the modulation of allergen induced inflammation.

    • Sofia Sirvent
    • Andres F. Vallejo
    • Marta E. Polak
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-14